Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

NCT06926842 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Type 2 Diabetes
Obesity

Interventions

DRUG: Petrelintide
OTHER: Placebo

Sponsor

Zealand Pharma

Collaborators

[object Object]